This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...